Intravitreal bevacizumab (avastin) in central retinal vein occlusion

To describe the effects of intravitreal bevacizumab in eyes with macular edema resulting from central retinal vein occlusions (CRVO). Retrospective consecutive case series of patients diagnosed with macular edema from CRVO who received intravitreal bevacizumab. Thirty eyes of 29 patients with an ave...

Full description

Saved in:

Bibliographic Details
Published in:	Retina (Philadelphia, Pa.) Vol. 27; no. 8; p. 1013
Main Authors:	Hsu, Jason, Kaiser, Richard S, Sivalingam, Arunan, Abraham, Prema, Fineman, Mitchell S, Samuel, Michael A, Vander, James F, Regillo, Carl D, Ho, Allen C
Format:	Journal Article
Language:	English
Published:	United States 01.10.2007
Subjects:	Aged Aged, 80 and over Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Bevacizumab Follow-Up Studies Humans Injections Macular Edema - drug therapy Macular Edema - etiology Middle Aged Retinal Vein Occlusion - complications Retinal Vein Occlusion - drug therapy Retrospective Studies Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity Vitreous Body
ISSN:	0275-004X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!